{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"non-progressive-predominantly-posterior-cavitating-leukoencephalopathy-with-peripheral-neuropathy","columns":[{"gene":"","key":"population-c2d56e8de65f29edf383","label":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","mondoId":"MONDO:0018576","onsetQualifier":null,"originColumnKey":"MONDO:0018576/ORPHA:436271","originalViews":[{"key":"MONDO:0018576/ORPHA:436271","label":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","scopeLabel":"ORPHA:436271","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["01ff44c2c517b4e3069b27585a40a386ed7810654bd641a8e1a732b64cdb9321","03a4dd60e16d218f7e3472aaf152bf481843f5659774f0dbaf6597ac027f5dc5","046b7059fb73852a8307d2fc617dbdec6a88bf0379502239d5fb8116ff94eeae","088d0b2aeb9255849a11f3f4aa78e9e8a9ea127dacee4f8921d2a361a236da12","13675c0d988bc6ba26c02e0d2fa2f2282d9ee607f967fd45fe688038816c773a","144fa3d474d40614bb00d72de6a6e7d2fd96f5d56a2ca204b43fa6a9b7bb56dd","1bbe3e512a0f243d90a6047f63fbda9135fe645d99fd75421ffaed3318edbf36","26e7de1284bbecaaa02af0a4026caa49a66949ef51b1dd9be5a05d6f6cedd13c","2ebdc6994960c7ab759c206144ad681dc9b5b3aa5574a07b8c4ccbdfd518aa26","2fa6178f84295f2ec14c047aecbf12c30cf1680bfc76fb519b96ead46444ef16","3236bdc2371cc2815a9e379818f8d8d4b085c51f7a8db6f667dbb2763794a2e6","3d9fd69389bdb9d67ef9edab872591a9f41bb199f74df2e1116e2ad7084d1b59","4ab11d620aa1e5a76c17dbd1aab7f4eec5339597b65f9fa7f43bad4a5033b827","612bc96cb40e7437df962269b6b024f1227fed22312bda17a31b0f811b9562a9","616683f1a21ace73d2fe77d2f2a051914b318fd00f111568d2c83dba71520678","63cf0a982b3a18b73abb224227e363bfc65ae98555767daabf99ad0cf127eb3b","63d775ebba1761962dc61a1843d64b41097ae3f058fb6fd57cc5c845f3091868","764d34d7ba13b1cf312ad5ccb11e00677f07ba1f03e044d84adea612729ba0ba","78a829595da324bf18735b96e2e16d274bc54b1c2b90c7f7ce1a65624560316f","7a4296bb45d4b73e0c04fb194865f336ff500251439d5e3bcf8ca0faa98e29f8","886ceba48d075b682a77c3e2e84d6a000904eb1da0b49e7d697a5dbab22414ec","8ec63142ea6cda5b8f22c2ce9f1c62648abd71dd9988fbdadf8253513d518364","9225bb10ce8ce9ee06a396a0aad8055cb62905e1133db414f85536a2276edf9d","95f474bd7c6b8fa76f36d21bcfe8aa490bd12b3571136273203d6fa3b33e280e","990a947acf71944dd54371f418aa6b05aa0a45c5520a172f4f84b325baff4f36","a5a882db23e374e29fa5708fd60e5c2d6a3b0cc2d2fe5a1f479b6bca15a22bdb","ab0399311444c92630a52aef5fd0efbc5dd978e051bfa374bf5638e8b26fd2a4","c3fc24241497a9b4ef83c49ac2b059b7048c06bc3698d245a128f59eaba7fcfe","cd292935af5bda5cc1137fd3519d2f207989dca9129beb98124adb777e1d9835","ce0109f36e91132b18870578467b9d709ae716bfc3905a5090286e12016b19da","d7bb029b4f411411ed3402ef72f05f9043e13d4fd145d706154b30863ea32693","dbe27a6241ff69138ba71c9413fd66c844212c249e2059ca0be46b078e037c07","df4b031c36edc4221e48bd42033e598231ed2aaf4f41c21c27aed9ef81fab7c1","e8f5b840e457fc81ef4c77e943c11d2c268c2be13cc8f407687dfd98290b335a","ee5b82cd79471bbca1f8f669e7fd9492218c38f933ae2d9df1c06b891b523bc0","f65005ac573f338bafafb4a0f9eefa4b2e9f75c1042bb30bc37b653409db7e99","fbb7fc70863a7b96cae375a9687e85e2fa4cdfccb78ca1cdba85fe0304aff9c7","fcd5400d62b8ac882be6b5fcbb485b469f543489d737a1e35a03d5f9baad7fb2"],"recordQualifiers":{},"scopeLabel":"ORPHA:436271","sourceIds":["ORPHA:436271"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-c2d56e8de65f29edf383"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007256","HP:0003355","HP:0001903","HP:0001251","HP:0008619","HP:0001410","HP:0000750"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":38,"sourceGroups":{"orphanet":38}},"features":[{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":true},{"hpoId":"HP:0003355","label":"Aminoaciduria","primary":true},{"hpoId":"HP:0001903","label":"Anemia","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0008619","label":"Bilateral sensorineural hearing impairment","primary":true},{"hpoId":"HP:0001410","label":"Decreased liver function","primary":true},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":true},{"hpoId":"HP:0002376","label":"Developmental regression","primary":false},{"hpoId":"HP:0006555","label":"Diffuse hepatic steatosis","primary":false},{"hpoId":"HP:0001262","label":"Excessive daytime somnolence","primary":false},{"hpoId":"HP:0002875","label":"Exertional dyspnea","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0030195","label":"Fatigable weakness of swallowing muscles","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0003324","label":"Generalized muscle weakness","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0003076","label":"Glycosuria","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0003109","label":"Hyperphosphaturia","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0002490","label":"Increased CSF lactate","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0003128","label":"Lactic acidosis","primary":false},{"hpoId":"HP:0001270","label":"Motor delay","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0000580","label":"Pigmentary retinopathy","primary":false},{"hpoId":"HP:0006980","label":"Progressive leukoencephalopathy","primary":false},{"hpoId":"HP:0007133","label":"Progressive peripheral neuropathy","primary":false},{"hpoId":"HP:0000093","label":"Proteinuria","primary":false},{"hpoId":"HP:0000508","label":"Ptosis","primary":false},{"hpoId":"HP:0001994","label":"Renal Fanconi syndrome","primary":false},{"hpoId":"HP:0000124","label":"Renal tubular dysfunction","primary":false},{"hpoId":"HP:0002747","label":"Respiratory insufficiency due to muscle weakness","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0040291","label":"Skeletal muscle steatosis","primary":false},{"hpoId":"HP:0001285","label":"Spastic tetraparesis","primary":false},{"hpoId":"HP:0002013","label":"Vomiting","primary":false}],"ledeHtml":"A rare mitochondrial disease characterized by a distinctive MRI pattern of cavitating leukodystrophy, predominantly in the posterior region of the cerebral hemispheres. The clinical picture varies widely between acute neurometabolic decompensation in infancy with loss of developmental milestones, seizures, and pyramidal signs rapidly evolving into spastic tetraparesis, to subtle neurological symptoms presenting in adolescence. The disease course tends to stabilize over time in most patients, and marked recovery of milestones may be observed.","mondoId":"MONDO:0018576","node":{"canonicalSlug":"non-progressive-predominantly-posterior-cavitating-leukoencephalopathy-with-peripheral-neuropathy","comparisons":[{"documentSha256":"2990e4f9d7f08689d205b6463742b3a1fdfbbbdc1bd59931b20bced9cd0da506","key":"legacy-non-progressive-predominantly-posterior-cavitating-leukoencephalopathy-with-peripheral-neuropathy","kind":"legacy","label":"non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","memberIds":["MONDO:0018576"],"mondoId":"MONDO:0018576","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/non-progressive-predominantly-posterior-cavitating-leukoencephalopathy-with-peripheral-neuropathy.2990e4f9d7f08689d205b6463742b3a1fdfbbbdc1bd59931b20bced9cd0da506.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","originalSourceId":"ORPHA:436271","paragraphs":["A rare mitochondrial disease characterized by a distinctive MRI pattern of cavitating leukodystrophy, predominantly in the posterior region of the cerebral hemispheres. The clinical picture varies widely between acute neurometabolic decompensation in infancy with loss of developmental milestones, seizures, and pyramidal signs rapidly evolving into spastic tetraparesis, to subtle neurological symptoms presenting in adolescence. The disease course tends to stabilize over time in most patients, and marked recovery of milestones may be observed."],"rawAttribution":"ORPHA:436271","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:03:48Z","upstream":"ORPHA:436271","url":"https://rarediseases.info.nih.gov/diseases/21819"},"ownColumnKeys":["population-c2d56e8de65f29edf383"],"publication":"published","relationships":[{"kind":"parent","label":"mitochondrial oxidative phosphorylation disorder","mondoId":"MONDO:0016387","slug":"mitochondrial-oxidative-phosphorylation-disorder"},{"kind":"parent","label":"leukodystrophy","mondoId":"MONDO:0019046","slug":"leukodystrophy"},{"kind":"parent","label":"hereditary peripheral neuropathy","mondoId":"MONDO:0020127","slug":"hereditary-peripheral-neuropathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"01ff44c2c517b4e3069b27585a40a386ed7810654bd641a8e1a732b64cdb9321","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000124","is_excluded":false,"label":"Renal tubular dysfunction","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"03a4dd60e16d218f7e3472aaf152bf481843f5659774f0dbaf6597ac027f5dc5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001285","is_excluded":false,"label":"Spastic tetraparesis","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"046b7059fb73852a8307d2fc617dbdec6a88bf0379502239d5fb8116ff94eeae","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003355","is_excluded":false,"label":"Aminoaciduria","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"088d0b2aeb9255849a11f3f4aa78e9e8a9ea127dacee4f8921d2a361a236da12","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001994","is_excluded":false,"label":"Renal Fanconi syndrome","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"13675c0d988bc6ba26c02e0d2fa2f2282d9ee607f967fd45fe688038816c773a","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008619","is_excluded":false,"label":"Bilateral sensorineural hearing impairment","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"144fa3d474d40614bb00d72de6a6e7d2fd96f5d56a2ca204b43fa6a9b7bb56dd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0006555","is_excluded":false,"label":"Diffuse hepatic steatosis","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1bbe3e512a0f243d90a6047f63fbda9135fe645d99fd75421ffaed3318edbf36","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007133","is_excluded":false,"label":"Progressive peripheral neuropathy","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"26e7de1284bbecaaa02af0a4026caa49a66949ef51b1dd9be5a05d6f6cedd13c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003324","is_excluded":false,"label":"Generalized muscle weakness","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2ebdc6994960c7ab759c206144ad681dc9b5b3aa5574a07b8c4ccbdfd518aa26","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2fa6178f84295f2ec14c047aecbf12c30cf1680bfc76fb519b96ead46444ef16","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3236bdc2371cc2815a9e379818f8d8d4b085c51f7a8db6f667dbb2763794a2e6","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3d9fd69389bdb9d67ef9edab872591a9f41bb199f74df2e1116e2ad7084d1b59","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4ab11d620aa1e5a76c17dbd1aab7f4eec5339597b65f9fa7f43bad4a5033b827","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003109","is_excluded":false,"label":"Hyperphosphaturia","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"612bc96cb40e7437df962269b6b024f1227fed22312bda17a31b0f811b9562a9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"616683f1a21ace73d2fe77d2f2a051914b318fd00f111568d2c83dba71520678","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"63cf0a982b3a18b73abb224227e363bfc65ae98555767daabf99ad0cf127eb3b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001262","is_excluded":false,"label":"Excessive daytime somnolence","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"63d775ebba1761962dc61a1843d64b41097ae3f058fb6fd57cc5c845f3091868","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"764d34d7ba13b1cf312ad5ccb11e00677f07ba1f03e044d84adea612729ba0ba","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030195","is_excluded":false,"label":"Fatigable weakness of swallowing muscles","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"78a829595da324bf18735b96e2e16d274bc54b1c2b90c7f7ce1a65624560316f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7a4296bb45d4b73e0c04fb194865f336ff500251439d5e3bcf8ca0faa98e29f8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000093","is_excluded":false,"label":"Proteinuria","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"886ceba48d075b682a77c3e2e84d6a000904eb1da0b49e7d697a5dbab22414ec","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0006980","is_excluded":false,"label":"Progressive leukoencephalopathy","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8ec63142ea6cda5b8f22c2ce9f1c62648abd71dd9988fbdadf8253513d518364","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000580","is_excluded":false,"label":"Pigmentary retinopathy","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9225bb10ce8ce9ee06a396a0aad8055cb62905e1133db414f85536a2276edf9d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003076","is_excluded":false,"label":"Glycosuria","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"95f474bd7c6b8fa76f36d21bcfe8aa490bd12b3571136273203d6fa3b33e280e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"990a947acf71944dd54371f418aa6b05aa0a45c5520a172f4f84b325baff4f36","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a5a882db23e374e29fa5708fd60e5c2d6a3b0cc2d2fe5a1f479b6bca15a22bdb","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ab0399311444c92630a52aef5fd0efbc5dd978e051bfa374bf5638e8b26fd2a4","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001410","is_excluded":false,"label":"Decreased liver function","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c3fc24241497a9b4ef83c49ac2b059b7048c06bc3698d245a128f59eaba7fcfe","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002013","is_excluded":false,"label":"Vomiting","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cd292935af5bda5cc1137fd3519d2f207989dca9129beb98124adb777e1d9835","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040291","is_excluded":false,"label":"Skeletal muscle steatosis","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ce0109f36e91132b18870578467b9d709ae716bfc3905a5090286e12016b19da","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001270","is_excluded":false,"label":"Motor delay","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d7bb029b4f411411ed3402ef72f05f9043e13d4fd145d706154b30863ea32693","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002747","is_excluded":false,"label":"Respiratory insufficiency due to muscle weakness","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dbe27a6241ff69138ba71c9413fd66c844212c249e2059ca0be46b078e037c07","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002490","is_excluded":false,"label":"Increased CSF lactate","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"df4b031c36edc4221e48bd42033e598231ed2aaf4f41c21c27aed9ef81fab7c1","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000508","is_excluded":false,"label":"Ptosis","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e8f5b840e457fc81ef4c77e943c11d2c268c2be13cc8f407687dfd98290b335a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003128","is_excluded":false,"label":"Lactic acidosis","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ee5b82cd79471bbca1f8f669e7fd9492218c38f933ae2d9df1c06b891b523bc0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f65005ac573f338bafafb4a0f9eefa4b2e9f75c1042bb30bc37b653409db7e99","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fbb7fc70863a7b96cae375a9687e85e2fa4cdfccb78ca1cdba85fe0304aff9c7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fcd5400d62b8ac882be6b5fcbb485b469f543489d737a1e35a03d5f9baad7fb2","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:436271","disease_name":"Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002875","is_excluded":false,"label":"Exertional dyspnea","onset_id":null,"reference":"ORPHA:436271","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/21819\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:436271</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare mitochondrial disease characterized by a distinctive MRI pattern of cavitating leukodystrophy, predominantly in the posterior region of the cerebral hemispheres. The clinical picture varies widely between acute neurometabolic decompensation in infancy with loss of developmental milestones, seizures, and pyramidal signs rapidly evolving into spastic tetraparesis, to subtle neurological symptoms presenting in adolescence. The disease course tends to stabilize over time in most patients, and marked recovery of milestones may be observed.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/21819\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"non-progressive-predominantly-posterior-cavitating-leukoencephalopathy-with-peripheral-neuropathy","sourceDocuments":[{"name":"GARD: Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy","reviewed":null,"source_release":"2026-10-21T17:03:48Z","url":"https://rarediseases.info.nih.gov/diseases/21819"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy"},"schemaVersion":1}
